CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 168 filers reported holding CARDLYTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $152,000 | -57.8% | 16,150 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $360,000 | -60.6% | 16,150 | -2.7% | 0.00% | -50.0% |
| Q1 2022 | $913,000 | -21.5% | 16,600 | -5.7% | 0.01% | -20.0% |
| Q4 2021 | $1,163,000 | -22.8% | 17,600 | -1.9% | 0.01% | -23.1% |
| Q3 2021 | $1,507,000 | -34.0% | 17,950 | -0.3% | 0.01% | -31.6% |
| Q2 2021 | $2,285,000 | +9.6% | 18,000 | -5.3% | 0.02% | +5.6% |
| Q1 2021 | $2,084,000 | -27.0% | 19,000 | -5.0% | 0.02% | -33.3% |
| Q4 2020 | $2,855,000 | +75.5% | 20,000 | -13.2% | 0.03% | +50.0% |
| Q3 2020 | $1,627,000 | -0.4% | 23,050 | -1.3% | 0.02% | -5.3% |
| Q2 2020 | $1,634,000 | +225.5% | 23,350 | +62.7% | 0.02% | +216.7% |
| Q1 2020 | $502,000 | -48.0% | 14,350 | -6.5% | 0.01% | -25.0% |
| Q4 2019 | $965,000 | +81.7% | 15,350 | -3.2% | 0.01% | +100.0% |
| Q3 2019 | $531,000 | +28.9% | 15,850 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $412,000 | +60.9% | 15,850 | +2.6% | 0.00% | +50.0% |
| Q1 2019 | $256,000 | – | 15,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |